# EDGAR Filing Document

**Accession Number:** 0001678848
**File Stem:** 0001213900-23-011782
**Filing Date:** 2023-2
**Character Count:** 5739
**Document Hash:** bb0a91f1d16826e54e1dab4c806dfdda
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-011782.hdr.sgml**: 20230215

**ACCESSION NUMBER**: 0001213900-23-011782

**CONFORMED SUBMISSION TYPE**: NT 10-Q

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230215

**DATE AS OF CHANGE**: 20230215

**EFFECTIVENESS DATE**: 20230215

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BITMIS CORP.
- **CENTRAL INDEX KEY:** 0001678848
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 981310024
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NT 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-214469
- **FILM NUMBER:** 23633498

**BUSINESS ADDRESS:**
- **STREET 1:** UNIT NO. 5784
- **STREET 2:** 152 CHARTERED SQUARE BUILDING, 212/19
- **CITY:** BANGKOK
- **STATE:** W1
- **ZIP:** 10500
- **BUSINESS PHONE:** 7026050123

**MAIL ADDRESS:**
- **STREET 1:** UNIT NO. 5784
- **STREET 2:** 152 CHARTERED SQUARE BUILDING, 212/19
- **CITY:** BANGKOK
- **STATE:** W1
- **ZIP:** 10500

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 12b-25**

---

| | |
|:---|:---|
| **NOTIFICATION OF LATE FILING** | SEC FILE NUMBER |
|  | 333-214469 |

---

(Check one): *☐ Form 10-K* *☐ Form 20-F* *☐ Form 11-K* *☒ Form 10-Q* *☐ Form 10-D* ☐ Form N-CEN <br>☐ Form N-CSR

For Quarter Ended: December 31, 2022

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

For the Transition Period Ended: Not Applicable

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable

**PART I--REGISTRANT INFORMATION**

---

| |
|:---|
| **Bitmis Corp.** |
| Full Name of Registrant |
| Former Name if Applicable |
| 1-17-1 Zhaojia Road |
| Xinglongtai District |
| Address of Principal Executive Office (Street and Number) |
| Panjin City, Liaoning Province<br> People's Republic of China |
| City, State and Zip Code |

---

**PART II--RULES 12b-25 (b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

**PART III--NARRATIVE**

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed period.

Based on consummation of a share exchange agreement and the closing of a reverse acquisition on December 30, 2022, the registrant has experienced a delay in preparing the Form 10-Q and the unaudited financial statements required to be included in the Form 10-Q for the quarter ended December 31, 2022, and needs additional time to complete the Form 10-Q and the unaudited financial statements for the quarter ended December 31, 2022.

**PART IV--OTHER INFORMATION**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Name and telephone number of person to contact in regard to this notification

<u>Sun Xiuzhi</u> <u>+86</u> <u>15842767931</u> <br> (Name) (Country Code) (Telephone Number) <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Is it anticipated that any significant change in results of operations
 from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report
 or portion thereof? ☐ Yes ☒ No If so, attach an explanation of the anticipated change, both narratively
 and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

**<u>Bitmis Corp.</u>**

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: February 15, 2023 | By: | /s/ Sun Xiuzhi |
|  |  | Sun Xiuzhi |
|  |  | Chief Financial Officer |

---

<u>INSTRUCTION</u>: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.